New ‘Immunoprofiler’ Initiative will Advance Drug Discovery, Precision Immunotherapy for Cancer – UCSF News Services
|
New 'Immunoprofiler' Initiative will Advance Drug Discovery, Precision Immunotherapy for Cancer
UCSF News Services UC San Francisco scientists have formed an innovative research alliance with three global pharmaceutical companies to improve patients' responses to cancer immunotherapy and to increase the effectiveness of immunotherapy across a wider range of … |
